Oral propranolol and retinopathy of prematurity
Phase 2
- Conditions
- Retinopathy of prematurity.Retinopathy of prematurity
- Registration Number
- IRCT20100512003915N21
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 72
Inclusion Criteria
Preterm infants with gestational age of less than 30 weeks
Birth weight less than 1250 grams
Stage 1 or 2 for retinopathy of prematurity
Exclusion Criteria
Infants with congenital anomalies
Congenital or acquired cardiovascular disease in neonate
Acute renal failure
Severe intra-ventricular hemorrhage
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The need to intervention (laser therapy or Avastin administration) in retinopathy of prematurity. Timepoint: Corrected gestational age 38 weeks (gestational age plus age after birth in weeks). Method of measurement: Ophthalmoscopic eye examination and performing laser therapy or Avastin administration.
- Secondary Outcome Measures
Name Time Method